Psychiatry & Behavioral
Task Force
Psychiatry
Nearly half of all U.S. adults will meet the criteria for a mental health condition at some point in their lifetime, creating a critical need for innovative treatments.
Task Force Highlights
40+
Years of psychiatry research experience
1,000+
Studies focusing on Schizophrenia, Bipolar Disorder, Depression, and Anxiety
18
Centers of Excellence across the U.S.
Overview
Leading Psychiatric Clinical Research
Complex psychiatric trials require specialized scientific and operational knowledge. CenExel's extensive team includes scientific, recruitment, rating, and operational experts — ensuring that your trials progress efficiently from first-participant-in to last-participant-out.
Our psychiatric clinical sciences team excels in designing first-in-human studies with unique biomarkers and critical endpoints. Expert raters and data monitors ensure high-quality efficacy and safety outcomes across even the most challenging protocols.
CenExel supports a wide range of conditions including mood disorders, anxiety disorders, behavioral disorders, combination disorders, and rare indications — across pediatric, adolescent, adult, and senior populations.
Conditions Covered
Psychiatric Conditions We Research
Our psychiatric research sites support a broad spectrum of conditions — from major depressive disorder and schizophrenia to rare and treatment-resistant indications.
Schizophrenia
Bipolar Disorder
Major Depressive Disorder (MDD)
Generalized Anxiety Disorder
Post-Traumatic Stress Disorder (PTSD)
ADHD (Adult & Pediatric)
Social Anxiety Disorder
Panic Disorder
Postpartum Depression (PPD)
Treatment-Resistant Depression
Schizophrenia – Pediatric
Bipolar Disorder – Pediatric
Our Approach
Why Sponsors Choose CenExel for Psychiatry
CenExel's psychiatric expertise goes beyond participant enrollment — we provide scientific consultation, rating integrity, and data quality that sponsors rely on for regulatory success.
01
Expert Rating Teams
Our expert raters and data monitors ensure high-quality efficacy and safety outcomes. Rating integrity is central to our psychiatric trial execution.
02
Biomarker Strategy
Our clinical sciences team designs first-in-human studies with unique biomarkers and critical endpoints — supporting go/no-go decisions earlier.
03
Diverse Populations
Access to diverse US metropolitan populations across 15 sites ensures your study reflects real-world patient demographics.
04
100%+ Enrollment
CenExel's in-house recruitment team consistently exceeds 100% of participant enrollment targets through precision targeting and culturally resonant messaging.
Phase Coverage
Supported Trial Phases
CenExel supports early and late phase psychiatric research — from first-in-human proof-of-concept studies through Phase IV post-market trials.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Our early phase capabilities include pharmacodynamic biomarker strategies, first-in-human studies, and proof-of-concept trial design — guided by Chief Scientific Officer Dr. Larry Ereshefsky, an internationally recognized KOL in CNS research with over 30 years of early phase expertise.
Leader
Psychiatry Task Force
CenExel supports a wide range of conditions including mood disorders, anxiety disorders, behavioral disorders, combination disorders, and rare indications — across pediatric, adolescent, adult, and senior populations.
Active Sites
15 Sites
CenExel Gaithersburg
CenExel Garden Grove
CenExel Atlanta
CenExel Marlton
CenExel Hollywood
Related Therapeutic Areas
Also in Psychiatry & Behavioral
Therapeutic Area
Behavioral Health
Mood disorders, anxiety, PTSD, and complex behavioral conditions.
Therapeutic Area
Addiction
Opioid, cannabis, and behavioral addiction trials across diverse populations.
Therapeutic Area
CNS
Central nervous system conditions with four decades of CenExel expertise.
Need More Help